Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Broggini

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Methods in Molecular Medicine|February 23, 2011
p53Transfectants in Ovarian CancerF Vikhanskaya, M Broggini
Clinical and Experimental Rheumatology|October 1, 1984
Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumaticaG Chelazzi, M Broggini
Current Medicinal Chemistry|November 11, 2010
PI3K/AKT/mTOR inhibitors in ovarian cancerM Mazzoletti, M Broggini
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
P53-independent caspase-mediated apoptosis in human leukaemic cells is induced by a DNA minor groove binder with antineoplastic activityS Marchini, M Ciro', M Broggini
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1995
Differential expression of c-fos proto-oncogene in two subclones derived from a human ovarian cancer cell lineM Cattabeni, M D'Incalci, M Broggini
International Journal of Clinical Pharmacology Research|January 1, 1986
Flurbiprofen versus ASA in influenza symptomatology: a double-blind studyM Broggini, V Bottà, C Benvenuti
Nucleic Acids Research|December 22, 1999
p73 competes with p53 and attenuates its response in a human ovarian cancer cell lineF Vikhanskaya, M D'Incalci, M Broggini
The Pharmacogenomics Journal|July 9, 2014
Genetic markers for prediction of treatment outcomes in ovarian cancerE Caiola, M Broggini, M Marabese
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 1, 1993
Effects of DNA damaging agents on gene expression in two human cancer cell linesF Vikhanskaya, M D'Incalci, M Broggini
Cancer Treatment Reports|June 1, 1983
Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing miceM Broggini, T Colombo, M D'Incalci
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Methods in Molecular Medicine|February 23, 2011
p53Transfectants in Ovarian CancerF Vikhanskaya, M Broggini
Clinical and Experimental Rheumatology|October 1, 1984
Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumaticaG Chelazzi, M Broggini
Current Medicinal Chemistry|November 11, 2010
PI3K/AKT/mTOR inhibitors in ovarian cancerM Mazzoletti, M Broggini
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
P53-independent caspase-mediated apoptosis in human leukaemic cells is induced by a DNA minor groove binder with antineoplastic activityS Marchini, M Ciro', M Broggini
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 1, 1995
Differential expression of c-fos proto-oncogene in two subclones derived from a human ovarian cancer cell lineM Cattabeni, M D'Incalci, M Broggini
International Journal of Clinical Pharmacology Research|January 1, 1986
Flurbiprofen versus ASA in influenza symptomatology: a double-blind studyM Broggini, V Bottà, C Benvenuti
Nucleic Acids Research|December 22, 1999
p73 competes with p53 and attenuates its response in a human ovarian cancer cell lineF Vikhanskaya, M D'Incalci, M Broggini
The Pharmacogenomics Journal|July 9, 2014
Genetic markers for prediction of treatment outcomes in ovarian cancerE Caiola, M Broggini, M Marabese
Cellular and Molecular Biology (Noisy-Le-Grand, France)|December 1, 1993
Effects of DNA damaging agents on gene expression in two human cancer cell linesF Vikhanskaya, M D'Incalci, M Broggini
Cancer Treatment Reports|June 1, 1983
Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing miceM Broggini, T Colombo, M D'Incalci
Pageof 18